✨
AI Summary
- Chinese biotech's rise: 0% to 31% of molecules licensed to Big Pharma.
- Tim Opler discusses rapid growth factors in the Chinese biotech sector.
- Significant increase in global pharmaceutical partnerships with Chinese firms.